| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Richard P. Valencia last filed a Form 4 in June 2019, as Director at TNDM. Richard P. Valencia's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 3,054 shares of TNDM. Net of sales, the TNDM filings show accumulation of 3,054 shares.
Richard P. Valencia has 5 Form 4 filings on record from June 2018 to June 2019, all as Director at Tandem Diabetes Care (TNDM), 2018–2019.
The 5 reported transactions were 3 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $99K and no sales.
The largest open-market purchase was 1,754 shares of TNDM at an average $28.50 on August 3, 2018, about $50K.
Shares as reported in the last Form 4 for each company; the most recent is from June 2019. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.